USANA Health Sciences Inc

USNA

USANA Health Sciences Inc (USNA) is a global direct-selling company that develops and manufactures nutritional, personal care, and weight management products. Founded in 1992, it is known for its focus on science-based health and wellness solutions, serving customers and independent distributors worldwide through a network marketing model.

$22.43 -0.08 (-0.33%)
🚫 USANA Health Sciences Inc does not pay dividends

Company News

The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
Benzinga • Prnewswire • January 19, 2026

The global consumer healthcare market is experiencing a structural shift where regulatory compliance and FDA approval have become critical competitive advantages. Major companies including Philip Morris, Celsius Holdings, USANA Health Sciences, and Medifast are advancing strategic initiatives focused on regulatory readiness, product integration, ...

Women Health & Beauty Supplements Market Analysis and Growth Forecast 2026-2030
GlobeNewswire Inc. • Researchandmarkets.Com • January 19, 2026

The global women's health and beauty supplements market is experiencing robust growth, expanding from USD 62.42 billion in 2024 to USD 66.38 billion in 2025, with projections to reach USD 91.42 billion by 2030 at a CAGR of 6.56%. Key growth drivers include ingredient innovation (collagen, probiotics, adaptogens), format evolution (gummies, powder...

Stock Market Today: Dow Jones, Nasdaq, S&P 500 Futures Advance— Applied Digital, Stellantis, Elastic In Focus (UPDATED)
Benzinga • Rishabh Mishra • October 10, 2025

U.S. stock futures rose on Friday after Thursday's market decline, with corporate earnings providing mixed results. Key focus was on potential trade discussions between U.S. and China, and market expectations of potential Federal Reserve interest rate cuts.

Xencor Surges 10.5%: Is This an Indication of Further Gains?
Benzinga • Zacks • September 12, 2024

Xencor shares surged 10.5% after the company announced a secondary stock offering to raise $175 million. The company plans to use the funds to support its pipeline development. However, earnings and revenue expectations for the upcoming quarter are negative, which may impact the stock's future performance.

Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds
Benzinga • Michael Juliano • June 27, 2024

Taking a multivitamin once a day has long been considered a path to better health, but a new study refutes that widely held belief. A study published in JAMA Network Open on Wednesday revealed that after tracking nearly 400,000 healthy adults for over 20 years, researchers found no link between regular multivitamin use and a lower risk of death, ...

Related Companies